$ASTC
ASTROTECH Corp

2023 Q4 Form 10-Q Financial Statement

#000143774923031659 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $1.115M $425.0K
YoY Change 323.95% 1018.42%
Cost Of Revenue $583.0K $242.0K
YoY Change 276.13% 656.25%
Gross Profit $532.0K $183.0K
YoY Change 392.59% 2950.0%
Gross Profit Margin 47.71% 43.06%
Selling, General & Admin $2.022M $1.646M
YoY Change 29.78% 0.24%
% of Gross Profit 380.08% 899.45%
Research & Development $1.578M $1.872M
YoY Change 15.69% 65.81%
% of Gross Profit 296.62% 1022.95%
Depreciation & Amortization $151.0K $149.0K
YoY Change 37.27% 67.42%
% of Gross Profit 28.38% 81.42%
Operating Expenses $3.600M $3.518M
YoY Change 23.2% 26.96%
Operating Profit -$3.068M -$3.335M
YoY Change 9.03% 20.61%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $427.0K $423.0K
YoY Change 7.83% 80.0%
Pretax Income -$2.641M -$2.900M
YoY Change 10.04% 16.0%
Income Tax
% Of Pretax Income
Net Earnings -$2.641M -$2.912M
YoY Change 9.22% 15.1%
Net Earnings / Revenue -236.86% -685.18%
Basic Earnings Per Share -$1.62 -$1.79
Diluted Earnings Per Share -$1.62 -$1.79
COMMON SHARES
Basic Shares Outstanding 1.702M 1.682M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $37.28M $39.00M
YoY Change -20.42% -20.32%
Cash & Equivalents $11.10M $13.09M
Short-Term Investments $26.18M $25.90M
Other Short-Term Assets $426.0K $300.0K
YoY Change -56.49% -66.7%
Inventory $2.065M $2.200M
Prepaid Expenses
Receivables $294.0K $391.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $40.06M $41.83M
YoY Change -18.95% -18.54%
LONG-TERM ASSETS
Property, Plant & Equipment $2.546M $2.545M
YoY Change 63.84% 88.52%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $30.00K $31.00K
YoY Change 172.73% 181.82%
Total Long-Term Assets $2.767M $2.802M
YoY Change 45.55% 86.68%
TOTAL ASSETS
Total Short-Term Assets $40.06M $41.83M
Total Long-Term Assets $2.767M $2.802M
Total Assets $42.83M $44.63M
YoY Change -16.57% -15.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $567.0K $646.0K
YoY Change 88.37% 125.09%
Accrued Expenses $1.747M $1.400M
YoY Change -4.22% -4.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $149.0K $200.0K
YoY Change 4.2% 41.84%
Total Short-Term Liabilities $2.314M $2.248M
YoY Change 1.98% 19.07%
LONG-TERM LIABILITIES
Long-Term Debt $96.00K $100.0K
YoY Change -31.43% -43.5%
Other Long-Term Liabilities $243.0K $100.0K
YoY Change 12.5% 56.25%
Total Long-Term Liabilities $243.0K $200.0K
YoY Change -31.74% -17.01%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.314M $2.248M
Total Long-Term Liabilities $243.0K $200.0K
Total Liabilities $2.557M $2.515M
YoY Change -2.59% 18.13%
SHAREHOLDERS EQUITY
Retained Earnings -$230.9M -$228.3M
YoY Change 4.64% 4.59%
Common Stock $190.6M $190.6M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $40.27M $42.12M
YoY Change
Total Liabilities & Shareholders Equity $42.83M $44.63M
YoY Change -16.57% -15.56%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$2.641M -$2.912M
YoY Change 9.22% 15.1%
Depreciation, Depletion And Amortization $151.0K $149.0K
YoY Change 37.27% 67.42%
Cash From Operating Activities -$1.800M -$3.050M
YoY Change -0.77% 24.95%
INVESTING ACTIVITIES
Capital Expenditures $157.0K $24.00K
YoY Change -45.1% -93.06%
Acquisitions
YoY Change
Other Investing Activities $5.000K $2.000M
YoY Change -102.04% -141.19%
Cash From Investing Activities -$152.0K $1.977M
YoY Change -71.37% -138.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -40.00K -$45.00K
YoY Change 2.56% -91.64%
NET CHANGE
Cash From Operating Activities -1.800M -$3.050M
Cash From Investing Activities -152.0K $1.977M
Cash From Financing Activities -40.00K -$45.00K
Net Change In Cash -1.992M -$1.118M
YoY Change -16.44% -86.33%
FREE CASH FLOW
Cash From Operating Activities -$1.800M -$3.050M
Capital Expenditures $157.0K $24.00K
Free Cash Flow -$1.957M -$3.074M
YoY Change -6.81% 10.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
280898
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
280898
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
280898
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
280898
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1712045
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1692045
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1701729
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1681729
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
10316
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
10316
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2022Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
001-34426
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
91-1273737
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
2105 Donley Drive, Suite 100
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Austin
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
78758
CY2023Q3 dei City Area Code
CityAreaCode
512
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
485-9530
CY2023Q3 dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
CY2023Q3 dei Trading Symbol
TradingSymbol
ASTC
CY2023Q3 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1701729
CY2023Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
13090000 usd
CY2023Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
14208000 usd
CY2023Q3 us-gaap Short Term Investments
ShortTermInvestments
25863000 usd
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
27919000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
391000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
225000 usd
CY2023Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1560000 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
1379000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
287000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
243000 usd
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
343000 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
373000 usd
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 usd
CY2023Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
296000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
365000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
41830000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
44713000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2545000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2670000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
226000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
262000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
31000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
30000 usd
CY2023Q3 us-gaap Assets
Assets
44632000 usd
CY2023Q2 us-gaap Assets
Assets
47675000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
646000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
546000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
567000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
633000 usd
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
723000 usd
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
1170000 usd
CY2023Q3 astc Operating And Finance Leases Liability Current
OperatingAndFinanceLeasesLiabilityCurrent
312000 usd
CY2023Q2 astc Operating And Finance Leases Liability Current
OperatingAndFinanceLeasesLiabilityCurrent
316000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2248000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
2665000 usd
CY2023Q3 astc Accrued Liabilities And Other Liabilities Noncurrent
AccruedLiabilitiesAndOtherLiabilitiesNoncurrent
39000 usd
CY2023Q2 astc Accrued Liabilities And Other Liabilities Noncurrent
AccruedLiabilitiesAndOtherLiabilitiesNoncurrent
0 usd
CY2023Q3 astc Operating And Finance Leases Liability Noncurrent
OperatingAndFinanceLeasesLiabilityNoncurrent
228000 usd
CY2023Q2 astc Operating And Finance Leases Liability Noncurrent
OperatingAndFinanceLeasesLiabilityNoncurrent
291000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
2515000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2956000 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
190643000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
190643000 usd
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
119000 usd
CY2023Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
119000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81366000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81002000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-228266000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-225354000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47675000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1507000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1453000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
42117000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
44719000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44632000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
425000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
38000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
242000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
32000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
183000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
6000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1646000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1642000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1872000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1129000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
3518000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2771000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3335000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2765000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
423000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
235000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2912000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2530000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2912000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2530000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1631000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1612000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.79
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.57
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2912000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2530000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-54000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-368000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2966000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2898000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
44719000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-54000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
364000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2912000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
42117000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
53236000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-368000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
387000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2530000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
50725000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2912000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2530000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
364000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
387000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
149000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
67000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
36000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
22000 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000 usd
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
4000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
166000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-18000 usd
CY2023Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-0 usd
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-2000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
195000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-52000 usd
CY2023Q3 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-1000 usd
CY2022Q3 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-0 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
100000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
118000 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-1000 usd
CY2023Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
394000 usd
CY2022Q3 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
558000 usd
CY2023Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-37000 usd
CY2022Q3 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-22000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3050000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2441000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24000 usd
CY2022Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
346000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1977000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5201000 usd
CY2023Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
CY2022Q3 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
500000 usd
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
45000 usd
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
38000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-45000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-538000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1118000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8180000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14208000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
26453000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13090000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
18273000 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
4000 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
59000 usd
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
2000 usd
CY2022Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
1000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 astc Numberof Patents Granted
NumberofPatentsGranted
18 pure
CY2023Q3 astc Numberof Wholly Owned Subsidiaries
NumberofWhollyOwnedSubsidiaries
3 pure
CY2023Q3 astc Number Of Locations Using Tracer1000
NumberOfLocationsUsingTracer1000
29 pure
CY2023Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
27370000 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1507000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
25863000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
29372000 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1453000 usd
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
27919000 usd
CY2023Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
25863000 usd
CY2023Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
27919000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
31000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
26000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
226000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
262000 usd
CY2023Q3 astc Operating And Finance Leases Operating Rightofuse Assets
OperatingAndFinanceLeasesOperatingRightofuseAssets
679000 usd
CY2023Q2 astc Operating And Finance Leases Operating Rightofuse Assets
OperatingAndFinanceLeasesOperatingRightofuseAssets
746000 usd
CY2023Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
131000 usd
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
161000 usd
CY2023Q3 astc Operating And Finance Leases Liabilities
OperatingAndFinanceLeasesLiabilities
540000 usd
CY2023Q2 astc Operating And Finance Leases Liabilities
OperatingAndFinanceLeasesLiabilities
607000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
124000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
136000 usd
CY2023Q3 astc Lessee Operating And Finance Leases Liabilities To Be Paid Remainder Of Fiscal Year
LesseeOperatingAndFinanceLeasesLiabilitiesToBePaidRemainderOfFiscalYear
260000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
141000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
94000 usd
CY2023Q3 astc Lessee Operating And Finance Leases Liabilities To Be Paid Year One
LesseeOperatingAndFinanceLeasesLiabilitiesToBePaidYearOne
235000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
0 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
27000 usd
CY2023Q3 astc Lessee Operating And Finance Leases Liabilities To Be Paid Year Two
LesseeOperatingAndFinanceLeasesLiabilitiesToBePaidYearTwo
27000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
0 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
27000 usd
CY2023Q3 astc Lessee Operating And Finance Leases Liabilities To Be Paid Year Three
LesseeOperatingAndFinanceLeasesLiabilitiesToBePaidYearThree
27000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
0 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
24000 usd
CY2023Q3 astc Lessee Operating And Finance Leases Liabilities To Be Paid Year Four
LesseeOperatingAndFinanceLeasesLiabilitiesToBePaidYearFour
24000 usd
CY2023Q3 astc Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2023Q3 astc Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2023Q3 astc Lessee Operating And Finance Leases Liabilities To Be Paid After Year Four
LesseeOperatingAndFinanceLeasesLiabilitiesToBePaidAfterYearFour
0 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
265000 usd
CY2023Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
308000 usd
CY2023Q3 astc Lessee Operating And Finance Lease Liability Payments Due
LesseeOperatingAndFinanceLeaseLiabilityPaymentsDue
573000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
13000 usd
CY2023Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
20000 usd
CY2023Q3 astc Lessee Operating And Finance Lease Liabilities Undiscounted Excess Amount
LesseeOperatingAndFinanceLeaseLiabilitiesUndiscountedExcessAmount
33000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
155000 usd
CY2023Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
157000 usd
CY2023Q3 astc Lessee Operating And Finance Leases Liabilities Current
LesseeOperatingAndFinanceLeasesLiabilitiesCurrent
312000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M6D
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061 pure
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.052 pure
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
41000 usd
CY2022Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
26000 usd
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
45000 usd
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
38000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3694000 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3671000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1149000 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1001000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2545000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2670000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
149000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
67000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
31000 usd
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
26000 usd
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
80000
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
72.1
CY2023Q2 astc Class Of Warrant Or Right Weighted Average Grant Date Fair Value Outstanding
ClassOfWarrantOrRightWeightedAverageGrantDateFairValueOutstanding
3747000 usd
CY2023 astc Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
P2Y7M6D
CY2023Q3 astc Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
0
CY2023Q3 astc Class Of Warrant Or Right Issued In Period Exercise Price
ClassOfWarrantOrRightIssuedInPeriodExercisePrice
0
CY2023Q3 astc Class Of Warrant Or Right Issuedin Period Weighted Average Grant Date Fair Value
ClassOfWarrantOrRightIssuedinPeriodWeightedAverageGrantDateFairValue
0 usd
CY2023Q3 astc Class Of Warrant Or Right Exercised In Period
ClassOfWarrantOrRightExercisedInPeriod
0
CY2023Q3 astc Class Of Warrant Or Right Exercised In Period Exercise Price
ClassOfWarrantOrRightExercisedInPeriodExercisePrice
0
CY2023Q3 astc Class Of Warrant Or Right Exercised In Period Weighted Average Grant Date Fair Value
ClassOfWarrantOrRightExercisedInPeriodWeightedAverageGrantDateFairValue
0 usd
CY2023Q3 astc Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
0
CY2023Q3 astc Class Of Warrant Or Right Expired In Period Exercise Price
ClassOfWarrantOrRightExpiredInPeriodExercisePrice
0
CY2023Q3 astc Class Of Warrant Or Right Expired In Period Weighted Average Grant Date Fair Value
ClassOfWarrantOrRightExpiredInPeriodWeightedAverageGrantDateFairValue
0 usd
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
80000
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
72.1
CY2023Q3 astc Class Of Warrant Or Right Weighted Average Grant Date Fair Value Outstanding
ClassOfWarrantOrRightWeightedAverageGrantDateFairValueOutstanding
3747000 usd
CY2023Q3 astc Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
P2Y4M6D
CY2023Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
80000
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
80000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-2912000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2530000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1631000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1612000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.79
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.57
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
10.1
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
175.5
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
38166000
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.34
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
116790000
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.16
CY2023Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
46000
CY2023Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
138.06
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
154910000
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.36
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
10.1
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
175.5
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
154910
CY2023Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2
P9Y6M29D
CY2023Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
14.36
CY2023Q3 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
13559
CY2023Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
44.35
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2900000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2500000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
486000 usd
CY2022Q4 astc Percent Of Deferred Payroll Tax Amount Paid
PercentOfDeferredPayrollTaxAmountPaid
1 pure
CY2021Q4 astc Percent Of Deferred Payroll Tax Amount Paid
PercentOfDeferredPayrollTaxAmountPaid
0.50 pure

Files In Submission

Name View Source Status
R21.htm Edgar Link pending
0001437749-23-031659-index-headers.html Edgar Link pending
0001437749-23-031659-index.html Edgar Link pending
0001437749-23-031659.txt Edgar Link pending
0001437749-23-031659-xbrl.zip Edgar Link pending
astc-20230930.xsd Edgar Link pending
astc20230930_10q.htm Edgar Link pending
ex_568499.htm Edgar Link pending
ex_568500.htm Edgar Link pending
ex_568501.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
logo.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
astc-20230930_cal.xml Edgar Link unprocessable
astc-20230930_def.xml Edgar Link unprocessable
astc-20230930_lab.xml Edgar Link unprocessable
astc-20230930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
astc20230930_10q_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending